Organon OGN Singulair — Revenue

Other product segments

Similar metrics at other companies

LENOther revenues — Revenue

$331.4M-6.8%

PRGOther Revenues — Revenue

$21.62M+165%

BDLOther Revenues — Revenue

$88K+27.5%

AEPCommercial Revenues — Revenue

$1.21B+15.4%

EQIXRecurring revenues — Revenue

$2.38B+10.9%

GCTProduct revenues — Revenue

$290.82M+28.9%

FAQ

What is Organon's singulair — revenue?

Organon (OGN) reported singulair — revenue of $40M in Q1 2026.

How has Organon's singulair — revenue changed year-over-year?

Organon's singulair — revenue decreased by 45.9% year-over-year, from $74M to $40M.

What is the long-term trend for Organon's singulair — revenue?

Over 4 years (2021 to 2025), Organon's singulair — revenue has grown at a -11.6% compound annual growth rate (CAGR), from $412M to $252M.

What does singulair — revenue mean?

This metric represents the total net sales generated by the Singulair product line within the established medicines portfolio. It reflects the market demand and commercial performance of this specific respiratory therapy asset over a given fiscal period. Monitoring these revenues helps investors assess the lifecycle stage and contribution of mature pharmaceutical products to the company's overall top-line results.